ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹262 Cr | ₹136 Cr | ₹144 Cr | ₹184 Cr | ₹190 Cr |
What is the latest Total Non-Current Liabilities ratio of ABBOTT INDIA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹262 Cr |
Mar2024 | ₹136 Cr |
Mar2023 | ₹144 Cr |
Mar2022 | ₹184 Cr |
Mar2021 | ₹190 Cr |
How is Total Non-Current Liabilities of ABBOTT INDIA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹262 Cr | 92.61 | |
Mar2024 | ₹136 Cr | -5.55 | |
Mar2023 | ₹144 Cr | -21.80 | |
Mar2022 | ₹184 Cr | -2.87 | |
Mar2021 | ₹190 Cr | - |
Compare Total Non-Current Liabilities of peers of ABBOTT INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ABBOTT INDIA | ₹69,149.3 Cr | -1.1% | -4.2% | 17.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹392,195.0 Cr | -0.3% | -3.4% | -6.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,417.0 Cr | -1.6% | -10.2% | 30.3% | Stock Analytics | |
CIPLA | ₹124,867.0 Cr | -1% | 4.8% | -1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,971.0 Cr | 1.2% | 3.9% | 9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,956.0 Cr | -0.6% | -1.1% | -9.9% | Stock Analytics |
ABBOTT INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ABBOTT INDIA | -1.1% |
-4.2% |
17.5% |
SENSEX | 2% |
0.1% |
1.8% |
You may also like the below Video Courses